Skip Navigation LinksHome > March 2014 - Volume 9 - Issue 3 > Systemic Therapy, Clinical Outcomes, and Overall Survival in...
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0000000000000065
Brief Reports

Systemic Therapy, Clinical Outcomes, and Overall Survival in Locally Advanced or Metastatic Pulmonary Carcinoid: A Brief Report

Forde, Patrick M. MD*; Hooker, Craig M. MPH; Boikos, Sosipatros A. MD*; Petrini, Iacope MD§; Giaccone, Giuseppe MD§; Rudin, Charles M. MD, PhD*; Yang, Stephen C. MD; Illei, Peter B. MD; Hann, Christine L. MD, PhD*; Ettinger, David S. MD*; Brahmer, Julie R. MD*; Kelly, Ronan J. MD, MBA*

Collapse Box

Abstract

Background:

Data to guide the management of advanced pulmonary carcinoid (APC) come from retrospective reports and subgroup analyses of trials that included mainly extrapulmonary carcinoid tumors. We report the largest series to date of 49 patients with locally advanced or metastatic pulmonary carcinoid.

Methods:

The Johns Hopkins Pathology Database was reviewed for APC patients treated between January 1992 and December 2012. Data on time to recurrence, progression-free survival, and overall survival were estimated by using the Kaplan–Meier method.

Results:

Forty-nine patients were treated for APC in the specified time period. Median time to recurrence after surgical resection was 2.5 years (atypical carcinoid [AC] versus typical carcinoid [TC], 2.5 versus 6.3 years; p = 0.063). Median survival with advanced disease was 7.1 years and significantly longer for TC compared with AC (10.2 versus 4 years; p = 0.009). Among the diverse systemic therapies used, responses occurred in four of 17 patients (23.5%) who received platinum/etoposide with a median progression-free survival of 7 months.

Conclusion:

Although systemic chemotherapy has moderate activity for APC, novel approaches are required. TC and AC, although both classified as pulmonary carcinoid, are clearly different clinical and molecular entities and require separate treatment paradigms in the advanced/metastatic setting.

Copyright © 2013 by the International Association for the Study of Lung Cancer

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Other Ways to Connect

Twitter
twitter.com/JTOonline

 



Visit JTO.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.